InterCure Ltd. Meeting Adjourned Due to Lack of Quorum
Ticker: INCR · Form: 6-K · Filed: Oct 28, 2024 · CIK: 1857030
| Field | Detail |
|---|---|
| Company | Intercure Ltd. (INCR) |
| Form Type | 6-K |
| Filed Date | Oct 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: meeting-adjournment, shareholder-meeting, corporate-governance
TL;DR
InterCure's shareholder meeting postponed to Nov 4 due to no quorum.
AI Summary
InterCure Ltd. held an Extraordinary General Meeting of Shareholders on October 28, 2024, which was adjourned for one week due to a lack of quorum. The meeting will now reconvene on November 4, 2024, at 4:00 p.m. Israel time, at the offices of Doron Tikotzky Kantor Gutman & Amit Gross.
Why It Matters
The adjournment of the shareholder meeting may indicate a lack of consensus or engagement among major shareholders, potentially delaying important corporate decisions.
Risk Assessment
Risk Level: low — The adjournment is a procedural matter and does not inherently signal financial distress or significant operational issues.
Key Players & Entities
- InterCure Ltd. (company) — Registrant
- October 28, 2024 (date) — Date of initial meeting
- November 4, 2024 (date) — Date of reconvened meeting
- Doron Tikotzky Kantor Gutman & Amit Gross (company) — Company's attorneys
FAQ
What was the reason for the adjournment of the Extraordinary General Meeting?
The meeting was adjourned due to a lack of quorum.
When will the Extraordinary General Meeting be reconvened?
The meeting will be reconvened on Monday, November 4, 2024.
At what time will the reconvened meeting take place?
The meeting will take place at 4:00 p.m. Israel time.
Where will the reconvened meeting be held?
The meeting will be held at the offices of the Company's attorneys, Doron Tikotzky Kantor Gutman & Amit Gross.
What is the Commission File Number for InterCure Ltd.'s filing?
The Commission File Number is 001-40614.
Filing Stats: 216 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2024-10-28 16:30:17
Filing Documents
- form6-k.htm (6-K) — 17KB
- 0001493152-24-042691.txt ( ) — 18KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INTERCURE LTD. Date: October 28, 2024 /s/ Amos Cohen Amos Cohen Chief Financial Officer